Emerging Treatments in C Difficile

Dr. Carl V. Crawford led a panel in discussing treatments in the pipeline for CDI.

A group of experts recently presented data and knowledge on the ongoing struggle to reduce the spread and treat clostridium difficile infections (CDI).

A team, led by Carl V. Crawford, MD, Weill Cornell Medicine, presented on Nov. 10 during the Institutional Perspectives in Infectious Diseases: Management of C. Difficile.

Joining Crawford were Andrea Betesh, MD, Harjot K Singh, MD, and Charlie Buffie, MD, PhD, all of Weill Cornell Medicine. The 4 experts discussed best treatment options for patients, understanding the disease, and what treatments and clinical trials are emerging in the field